A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects
Clinical trial NCT02120352 · COMPLETED
Trial details
- NCT number
- NCT02120352
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-28
- Primary completion
- 2015-08-13
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.